Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism
We aimed to analyze the pre- and posttreatment serum asymmetric dimethylarginine (ADMA), nitrate (NO3), vitamin B12 and homocysteine levels in pulmonary embolism (PTE) patients and to determine the prognostic value of these variables in predicting chronic thromboembolic pulmonary hypertension (CTEPH...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2011/215057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549878929031168 |
|---|---|
| author | Murat Altuntaş Figen Atalay Murat Can Remzi Altın Meltem Tor |
| author_facet | Murat Altuntaş Figen Atalay Murat Can Remzi Altın Meltem Tor |
| author_sort | Murat Altuntaş |
| collection | DOAJ |
| description | We aimed to analyze the pre- and posttreatment serum asymmetric dimethylarginine (ADMA), nitrate (NO3), vitamin B12 and homocysteine levels in pulmonary embolism (PTE) patients and to determine the prognostic value of these variables in predicting chronic thromboembolic pulmonary hypertension (CTEPH). This study was conducted in 64 patients. The patients were classified into the two groups: patients with normal pulmonary artery pressure (PAP) (group I) and patients with high PAP with persistent lung perfusion defects or who died at the end of 3 months of therapy (group II). We found statistically significant differences between two groups with respect to the partial oxygen pressure, the oxygen saturation, and the PAP, but there was no difference between the two groups with respect to the pretreatment ADMA, NO3, or homocysteine levels. The vitamin B12 levels were higher in group II. The NO3 levels increased and the ADMA and vitamin B12 levels decreased with treatment in both groups. These results suggest that these parameters are not predictive of the development of CTEPH. |
| format | Article |
| id | doaj-art-b73d6cd55c614165942f5fd07d107452 |
| institution | Kabale University |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-b73d6cd55c614165942f5fd07d1074522025-02-03T06:08:19ZengWileyMediators of Inflammation0962-93511466-18612011-01-01201110.1155/2011/215057215057Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary EmbolismMurat Altuntaş0Figen Atalay1Murat Can2Remzi Altın3Meltem Tor4Department of Pulmonary Medicine, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, TurkeyDepartment of Pulmonary Medicine, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, TurkeyDepartment of Biochemistry, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, TurkeyDepartment of Pulmonary Medicine, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, TurkeyDepartment of Pulmonary Medicine, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, TurkeyWe aimed to analyze the pre- and posttreatment serum asymmetric dimethylarginine (ADMA), nitrate (NO3), vitamin B12 and homocysteine levels in pulmonary embolism (PTE) patients and to determine the prognostic value of these variables in predicting chronic thromboembolic pulmonary hypertension (CTEPH). This study was conducted in 64 patients. The patients were classified into the two groups: patients with normal pulmonary artery pressure (PAP) (group I) and patients with high PAP with persistent lung perfusion defects or who died at the end of 3 months of therapy (group II). We found statistically significant differences between two groups with respect to the partial oxygen pressure, the oxygen saturation, and the PAP, but there was no difference between the two groups with respect to the pretreatment ADMA, NO3, or homocysteine levels. The vitamin B12 levels were higher in group II. The NO3 levels increased and the ADMA and vitamin B12 levels decreased with treatment in both groups. These results suggest that these parameters are not predictive of the development of CTEPH.http://dx.doi.org/10.1155/2011/215057 |
| spellingShingle | Murat Altuntaş Figen Atalay Murat Can Remzi Altın Meltem Tor Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism Mediators of Inflammation |
| title | Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism |
| title_full | Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism |
| title_fullStr | Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism |
| title_full_unstemmed | Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism |
| title_short | Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism |
| title_sort | serum asymmetric dimethylarginine nitrate vitamin b12 and homocysteine levels in individuals with pulmonary embolism |
| url | http://dx.doi.org/10.1155/2011/215057 |
| work_keys_str_mv | AT murataltuntas serumasymmetricdimethylargininenitratevitaminb12andhomocysteinelevelsinindividualswithpulmonaryembolism AT figenatalay serumasymmetricdimethylargininenitratevitaminb12andhomocysteinelevelsinindividualswithpulmonaryembolism AT muratcan serumasymmetricdimethylargininenitratevitaminb12andhomocysteinelevelsinindividualswithpulmonaryembolism AT remzialtın serumasymmetricdimethylargininenitratevitaminb12andhomocysteinelevelsinindividualswithpulmonaryembolism AT meltemtor serumasymmetricdimethylargininenitratevitaminb12andhomocysteinelevelsinindividualswithpulmonaryembolism |